Glycemic Management

Older children with newly diagnosed type 1 diabetes who received intensive diabetes management with automated insulin delivery had no difference in pancreatic C-peptide levels compared with standard care, according to study data.

Adults who improve from prediabetes to normoglycemia do not have a lower risk for death compared with those with persistent prediabetes, but lifestyle modification can help reduce mortality risk, according to study data.

Adults with type 1 diabetes who used an automated insulin delivery system with settings changed by the system instead of a provider had improvements in time in range and HbA1c at 13 weeks, according to a speaker.

A strong correlation exists between time below range of 54 mg/dL and time below range of 70 mg/dL, though the difference between the two values varies based on continuous glucose monitoring type, according to study data.

The FDA approved bexagliflozin, an oral SGLT2 inhibitor, to improve glycemic control for adults with type 2 diabetes, according to a company press release.

The FDA has approved a label update to permit an oral GLP-1 receptor agonist to be used as a first-line medication for adults with type 2 diabetes, according to a company press release.

Data from previous HbA1c levels, fasting plasma glucose, duration of type 2 diabetes and diabetes medication use may predict long-term glycemic profile, researchers reported in Clinical Epidemiology.

A technology-assisted behavioral sleep intervention was feasible and acceptable and may be effective for improving sleep duration or regularity for adults with type 1 diabetes, according to data from a pilot study.

Susan Weiner, MS, RDN, CDCES, FADCES, talks with Jennifer Smith, RD, LD, CDCES, to discuss steps women with type 1 diabetes can take to prepare for a healthy pregnancy.

Glycemic control was similar during the day compared with overnight for adults with type 1 diabetes using continuous glucose monitoring, regardless of HbA1c, according to study data.